Clinical Trial Update: Understanding Treatment Outcomes and Immunologic Mechanisms in Altuviiio Immune Tolerance Induction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on Altuviiio for immune tolerance induction in Hemophilia A with inhibitors, outlining treatment outcomes and immunologic mechanis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia with Inhibitors

Drugs mentioned

• Altuviiio (efanesoctocog alfa)

Snippet

Sponsor: Versiti Blood Health | Conditions: Hemophilia A With Inhibitor | Phase 4 | Status: NOT_YET_RECRUITING